Following the completion of audited financial statements, APCI is proud to announce a 2.64 percent Year-End True-Up Dividend on 2017 Generic Purchases.
The Centers for Medicare and Medicaid Services recently proposed regulations that would explore requiring PBMs in Medicare Part D to account for pharmacy DIR fees at point of sale.
Share your thoughts with NCPA by taking a 5-minute survey.
APCI offices will be closed Thursday and Friday.
NBC News has released an investigative report detailing PBM clawbacks and their effects on patients.